A Dyadic e-Health System on Enhancing Healthy Lifestyles of Older Adults With Sarcopenia - Trial NCT06088511
Access comprehensive clinical trial information for NCT06088511 through Pure Global AI's free database. This phase not specified trial is sponsored by The Hong Kong Polytechnic University and is currently Not yet recruiting. The study focuses on Sarcopenia. Target enrollment is 88 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
The Hong Kong Polytechnic University
Timeline & Enrollment
N/A
Jan 01, 2024
Jan 01, 2026
Primary Outcome
Changes of muscle strength,Changes of muscle mass,Changes of body mass index,Changes of waist circumference,Changes of fat mass,The Short Physical Performance Battery (SPPB) scale
Summary
Sarcopenia is defined as a reduction in muscle mass, muscle strength, and physical
 performance. Without proper management, sarcopenia may result in adverse health outcomes.
 Continuously maintain healthy lifestyle, such as being physically active, taking adequate
 protein in daily diet, are effective in preventing and managing sarcopenia. e-Health has been
 used successfully to translate evidence-based lifestyle interventions into daily practice by
 enhancing self-awareness, promoting self-monitor and sustaining self-management for other
 populations with different health problems.
 
 This project aims to develop, implement and evaluate the preliminary effects of an e-Health
 System to encourage older adults with sarcopenia to maintain healthy lifestyles (i.e. regular
 exercise and adequate intake of high-quality protein). Combining the concepts of smart
 health, the System aims to enhance users' self-monitoring (Level 1) and self-management
 (Level 2) of sarcopenia.
 
 Level 1 aims to enhance participants' and their family members' awareness of the risks of
 sarcopenia through continued monitoring. The System will perform baseline and regular
 subjective (such as self-administered questionnaires) and objective (such as activity levels
 by an embedded accelerometer) assessments on the participants. The embedded risk calculator
 in the System will analyze the scores obtained from different assessments and then recommend
 participants to follow the healthy lifestyle interventions in Level 2.
 
 Level 2 aims to enhance participants' and their family members' ability to manage the health
 problems related sarcopenia. The System will recommend two major evidence-based lifestyle
 interventions, including physical exercise and nutritional advice, based on the analysis of
 the assessment data in Level 1. These interventions will be conducted during the four
 face-to-face sessions and continuously self-practised at home. The interventions will provide
 interactive, immediate feedback to the participants and their family members to improve their
 involvement. The participants and their family members can monitor their progress via the
 System.
 
 The investigators hypothesize that the experimental group who has adopted the e-Health system
 in their daily life to manage sarcopenia will exhibit milder symptoms of sarcopenia and more
 sustainable self-management ability than participants in the control group who has received
 usual care.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06088511
Non-Device Trial

